Cited by 979Smoking Behavior and CessationNicotinic Acetylcholine Receptors StudySubstance Abuse Treatment and Outcomes

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics

Open access

Benowitz, Neal L.·2009·Annual Review of Pharmacology and Toxicology

DOI 10.1146/annurev.pharmtox.48.113006.094742PMC PMC2946180

Open this paper in CoChat — free account

Abstract

Nicotine sustains tobacco addiction, a major cause of disability and premature death. Nicotine binds to nicotinic cholinergic receptors, facilitating neurotransmitter release and thereby mediating the complex actions of nicotine in tobacco users. Dopamine, glutamate, and gamma aminobutyric acid release are particularly important in the development of nicotine dependence, and corticotropin-releasing factor appears to contribute to nicotine withdrawal. Nicotine dependence is highly heritable. Genetic studies indicate roles for nicotinic receptor subtypes, as well as genes involved in neuroplasticity and learning, in development of dependence. Nicotine is primarily metabolized by CYP 2A6, and variability in rate of metabolism contributes to vulnerability to tobacco dependence, response to smoking cessation treatment, and lung cancer risk. Tobacco addiction is much more common in persons with mental illness and substance abuse disorders, representing a high proportion of current smokers. Pharmacotherapeutic approaches to tobacco addiction include nicotine replacement, bupropion, and varenicline, the latter a selective nicotine receptor partial agonist.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev.pharmtox.48.113006.094742

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
The Health Consequences of Smoking: A Report of the Surgeon General
Office on Smoking (2004) · Cited by 2,414
Signs and Symptoms of Tobacco Withdrawal
Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,583
Self-citation
A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update
(2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.04.009 · Cited by 1,410
Synaptic plasticity and addiction
Kauer, J. A., & Malenka, R. C. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2234 · Cited by 1,397
Is there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Gonzales, D. (2006) · JAMA · doi:10.1001/jama.296.1.47 · Cited by 1,361
Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320

Show all 90 references

Research works printed but not linked: 4

Cent. Dis. Control Prev, 2002, MMWR, 51, 637
Colton CW, 2006, Prev. Chronic Dis., 3, A42
Slemmer JE, 2000, J. Pharmacol. Exp. Ther., 295, 321
Cahill K, 2007, Cochrane Database Syst. Rev., 2007, CD005353

Sorted by citations

Items 101–200 of 978

Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats
Grella, S. L., Funk, D. R., Coen, K., Li, Z., & Lê, A. D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.029 · Cited by 58
Nicotine Enhances Excitability of Medial Habenular Neurons via Facilitation of Neurokinin Signaling
Dao, D. Q., Perez, E. E., Teng, Y., Dani, J. A., & De Biasi, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2736-13.2014 · Cited by 56
A LC-MS/MS Method for Concurrent Determination of Nicotine Metabolites and Role of CYP2A6 in Nicotine Metabolism in U937 Macrophages: Implications in Oxidative Stress in HIV + Smokers
Jin, M., Earla, R., Shah, A. B., Earla, R. L., Gupte, R., Mitra, A. K., Kumar, A., & Kumar, S. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9283-6 · Cited by 56
Nicotinic receptor-based therapeutics and candidates for smoking cessation
Dwoskin, L. P., Smith, A. M., Wooters, T. E., Zhang, Z., Crooks, P. A., & Bardo, M. T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.002 · Cited by 57
Associations ofCYP2A6genotype with smoking behaviors in southern China
Liu, T., David, S. P., Tyndale, R. F., Wang, H., Zhou, Q., Ding, P., He, Y., Yu, X., Chen, W., Crump, C., et al. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03353.x · Cited by 55
Pharmacogenetics of Nicotine and Associated Smoking Behaviors
Tanner, J., Chenoweth, M. J., & Tyndale, R. F. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_3 · Cited by 56
Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse
Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00013-5 · Cited by 57
Pharmacogenetics of Nicotine Addiction: Role of Dopamine
Herman, A. I., DeVito, E. E., Jensen, K. P., & Sofuoglu, M. (2014) · Pharmacogenomics · doi:10.2217/pgs.13.246 · Cited by 59
Accidental ingestion of E-cigarette liquid nicotine in a 15-month-old child: an infant mortality case of nicotine intoxication
Seo, A. D., Kim, D. C., Yu, H. J., & Kang, M. J. (2016) · Korean Journal of Pediatrics · doi:10.3345/kjp.2016.59.12.490 · Cited by 52
Epigenetic and long-term effects of nicotine on biology, behavior, and health
Gould, T. J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106741 · Cited by 59
The impact of e-cigarette exposure on different organ systems: A review of recent evidence and future perspectives
Ali, N., Xavier, J., Engur, M., Mohanan, P., & de la Serna, J. B. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131828 · Cited by 57
Genetic regulation and manipulation of nicotine biosynthesis in tobacco: strategies to eliminate addictive alkaloids
Shoji, T., Hashimoto, T., & Saito, K. (2023) · Journal of Experimental Botany · doi:10.1093/jxb/erad341 · Cited by 52
Neurophysiology of Nicotine Addiction
Dani, J. A., Jenson, D., & Broussard, J. I. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-001 · Cited by 56
Thirdhand smoke: Chemical dynamics, cytotoxicity, and genotoxicity in outdoor and indoor environments
Bahl, V., Shim, H. J., Jacob, P., Dias, K., Schick, S. F., & Talbot, P. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.12.007 · Cited by 52
Assessing nicotine dependence using an oral nicotine free-choice paradigm in mice
Bağdaş, D., Diester, C. M., Riley, J., Carper, M., Alkhlaif, Y., Alomari, D., Alayoubi, H., Poklis, J. L., & Damaj, M. I. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107669 · Cited by 55
Enhanced Nicotine Metabolism in HIV-1–Positive Smokers Compared with HIV-Negative Smokers: Simultaneous Determination of Nicotine and its Four Metabolites in Their Plasma Using a Simple and Sensitive Electrospray Ionization Liquid Chromatography–Tandem Mass Spectrometry Technique
Earla, R., Ande, A., McArthur, C. P., Kumar, A., & Kumar, S. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055186 · Cited by 51
Hepatic CYP2B6 is altered by genetic, physiologic, and environmental factors but plays little role in nicotine metabolism
Koudsi, N. A., & Tyndale, R. F. (2010) · Xenobiotica · doi:10.3109/00498251003713958 · Cited by 51
A Mixed-Methods Study of Young Adults' Receptivity to Using Facebook for Smoking Cessation: If You Build It, Will They Come?
Ramo, D. E., Liu, H., & Prochaska, J. J. (2014) · American Journal of Health Promotion · doi:10.4278/ajhp.130326-qual-128 · Cited by 51
Association Between Smoking and Premenstrual Syndrome: A Meta-Analysis
Choi, S. H., & Hamidovic, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.575526 · Cited by 50
Cigarette Filter Ventilation and Smoking Protocol Influence Aldehyde Smoke Yields
Pauwels, C., Klerx, W. N. M., Pennings, J. L. A., Boots, A. W., van Schooten, F., Opperhuizen, A., & Talhout, R. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.7b00342 · Cited by 50
Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor
Li, X., Tae, H., Chu, Y., Jiang, T., Adams, D. J., & Yu, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107792 · Cited by 50
Plant Secondary Metabolites: Their Food and Therapeutic Importance
Kumar, S., Saini, R., Suthar, P., Kumar, V., & Sharma, R. D. (2022) · Springer eBooks · doi:10.1007/978-981-16-4779-6_12 · Cited by 57
Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes
Ande, A., McArthur, C. P., Kumar, A., & Kumar, S. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.816285 · Cited by 49
REVIEW: Cognitive effects of nicotine: genetic moderators
Herman, A. I., & Sofuoglu, M. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00213.x · Cited by 52
Tobacco smoking and its association with cognition in first episode psychosis patients
Hickling, L. M., Pérez‐Iglesias, R., de la Foz, V. O., Balanzá‐Martínez, V., McGuire, P. K., Crespo‐Facorro, B., & Ayesa‐Arriola, R. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.018 · Cited by 49
Psychological distress is associated with tobacco smoking and quitting behaviour in the Australian population: evidence from National Cross-Sectional Surveys
Leung, J., Gartner, C., Dobson, A., Lucke, J., & Hall, W. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.534070 · Cited by 46
Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral deficits
Wells, A. C., & Lotfipour, S. (2023) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2023.11628 · Cited by 50
AAV-Directed Persistent Expression of a Gene Encoding Anti-Nicotine Antibody for Smoking Cessation
Hicks, M. J., Rosenberg, J. B., De, B. P., Pagovich, O. E., Young, C. N., Qiu, J., Kaminsky, S. M., Hackett, N. R., Worgall, S., Janda, K. D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003611 · Cited by 48
Tobacco Addiction
Selby, P. L., & Zawertailo, L. A. (2022) · New England Journal of Medicine · doi:10.1056/nejmcp2032393 · Cited by 47
Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study
Yuan, J., Nelson, H. H., Butler, L. M., Carmella, S. G., Wang, R., Kuriger, J. K., Adams‐Haduch, J. M., Hecht, S. S., Gao, Y.-T., & Murphy, S. E. (2015) · International Journal of Cancer · doi:10.1002/ijc.29963 · Cited by 47
Noninvasive brain stimulation to suppress craving in substance use disorders: Review of human evidence and methodological considerations for future work
Hone‐Blanchet, A., Ciraulo, D. A., Pascual‐Leone, Á., & Fecteau, S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.10.001 · Cited by 48
Cigarette Smoking as a Risk Factor for Delirium in Hospitalized and Intensive Care Unit Patients. A Systematic Review
Hsieh, S.-J. J., Shum, M., Lee, A. N., Hasselmark, F., & Gong, M. N. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201301-001oc · Cited by 45
Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery
Terry, A. V., & Callahan, P. M. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty166 · Cited by 48
Nicotine Prevents Oxidative Stress-Induced Hippocampal Neuronal Injury Through α7-nAChR/Erk1/2 Signaling Pathway
Dong, Y., Bi, W., Zheng, K., Zhu, E., Wang, S., Xiong, Y., Chang, J., Jiang, J., Liu, B., Lu, Z., et al. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.557647 · Cited by 45
The Role of Smoking Cessation in the Prevention of Coronary Artery Disease
Pipe, A., Papadakis, S., & Reid, R. D. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0105-8 · Cited by 45
A one-year monitoring of nicotine use in sport: Frontier between potential performance enhancement and addiction issues
Marclay, F., Grata, E., Perrenoud, L., & Saugy, M. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.05.026 · Cited by 50
Pharmacotherapy for smoking cessation: present and future
Aubin, H.-J., Karila, L., & Reynaud, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796150837 · Cited by 39
Liraglutide attenuates nicotine self-administration as well as nicotine seeking and hyperphagia during withdrawal in male and female rats
Herman, R. J., Hayes, M. R., Audrain-McGovern, J. E., Ashare, R. L., & Schmidt, H. D. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06376-w · Cited by 46
Tobacco particulate matter self‐administration in rats: differential effects of tobacco type
Brennan, K. A., Crowther, A., Putt, F., Roper, V., Waterhouse, U., & Truman, P. (2013) · Addiction Biology · doi:10.1111/adb.12099 · Cited by 47
Sensory attributes of e-cigarette flavours and nicotine as mediators of interproduct differences in appeal among young adults
Leventhal, A. M., Cho, J., Barrington‐Trimis, J. L., Pang, R. D., Schiff, S. J., & Kirkpatrick, M. G. (2019) · Tobacco Control · doi:10.1136/tobaccocontrol-2019-055172 · Cited by 43
Pushes and pulls from below: Anatomical variation, articulation and sound change
Dediu, D., & Moisik, S. R. (2019) · Glossa a journal of general linguistics · doi:10.5334/gjgl.646 · Cited by 44
The genetic landscape of substance use disorders
Gerring, Z. F., Thorp, J. G., Treur, J. L., Verweij, K. J. H., & Derks, E. M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02547-z · Cited by 52
Abstinence-related expectancies predict smoking withdrawal effects: implications for possible causal mechanisms
Hendricks, P. S., & Leventhal, A. M. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3169-7 · Cited by 43
Emerging drugs for the treatment of tobacco dependence: 2014 update
Elrashidi, M. Y., & Ebbert, J. O. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.899580 · Cited by 43
Pharmacogenetics of smoking cessation therapy
Kortmann, G. L., Dobler, C. J., Bizarro, L., & Bau, C. H. D. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30978 · Cited by 41
Brain Nicotinic Acetylcholine Receptor Availability and Response to Smoking Cessation Treatment
Brody, A. L., Mukhin, A. G., Mamoun, M. S., Luu, T., Neary, M. K., Liang, L., Shieh, J., Sugar, C. A., Rose, J. E., & Mandelkern, M. A. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.138 · Cited by 44
Chronic Nicotine Exposure Alters the Neurophysiology of Habenulo-Interpeduncular Circuitry
Arvin, M. C., Jin, X.-T., Yan, Y., Wang, Y., Ramsey, M. D., Kim, V. J., Beckley, N. A., Henry, B. A., & Drenan, R. M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2816-18.2019 · Cited by 42
Circulating Extracellular Vesicles Containing Xenobiotic Metabolizing CYP Enzymes and Their Potential Roles in Extrahepatic Cells Via Cell–Cell Interactions
Gerth, K. A., Kodidela, S., Mahon, M., Haque, S., Verma, N., & Kumar, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246178 · Cited by 44
Tobacco, alcohol use and other risk factors for developing symptomatic COVID-19 vs asymptomatic SARS-CoV-2 infection: a case–control study from western Rajasthan, India
Saurabh, S., Verma, M. K., Gautam, V., Kumar, N., Jain, V., Goel, A. D., Gupta, M. K., Sharma, P. P., Bhardwaj, P., Singh, K., et al. (2020) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/traa172 · Cited by 42
Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection
Bono, F., Mutti, V., Fiorentini, C., & Missale, C. (2020) · Biomolecules · doi:10.3390/biom10071016 · Cited by 43
Counterfeit Electronic Cigarette Products with Mislabeled Nicotine Concentrations
Omaiye, E. E., Cordova, I., Davis, B. A., & Talbot, P. (2017) · Tobacco Regulatory Science · doi:10.18001/trs.3.3.10 · Cited by 41
Tobacco exposure and sleep disturbance in 498 208 UK Biobank participants
Boakye, D., Wyse, C. A., Morales-Celis, C. A., Biello, S. M., Bailey, M. E. S., Dare, S., Ward, J., Gill, J. M. R., Pell, J. P., & Mackay, D. (2017) · Journal of Public Health · doi:10.1093/pubmed/fdx102 · Cited by 41
Oral Contraceptives and Cigarette Smoking: A Review of the Literature and Future Directions
Allen, A. M., Weinberger, A. H., Wetherill, R. R., Howe, C. L., & McKee, S. A. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx258 · Cited by 41
Understanding the genetics and neurobiological pathways behind addiction (Review)
Popescu, A., Marian, M., Drăgoi, A. M., & Costea, R. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9976 · Cited by 49
Nicotine formulations impact reinforcement-related behaviors in a mouse model of vapor self-administration
Henderson, B. J., & Cooper, S. Y. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108732 · Cited by 39
Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure
Helen, G. S., Dempsey, D. A., Wilson, M., Jacob, P., & Benowitz, N. L. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04077.x · Cited by 39
Self-citation
Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies
Ashok, A. H., Mizuno, Y., & Howes, O. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05196-1 · Cited by 36
A Longitudinal Study of Risk Factors for Incident Drug Use in Adults: Findings from a Representative Sample of the US Population
Harrington, M., Robinson, J. A., Bolton, J. M., Sareen, J., & Bolton, J. M. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105601107 · Cited by 39
Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking After Abstinence
Liakoni, E., Edwards, K. C., Helen, G. S., Nardone, N., Dempsey, D. A., Tyndale, R. F., & Benowitz, N. L. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1238 · Cited by 37
Self-citation
An LC–MS/MS method for concurrent determination of nicotine metabolites and the role of CYP2A6 in nicotine metabolite-mediated oxidative stress in SVGA astrocytes
Ande, A., Earla, R., Jin, M., Silverstein, P. S., Mitra, A. K., Kumar, A., & Kumar, S. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.03.015 · Cited by 37
Development of Novel Pharmacotherapeutics for Tobacco Dependence: Progress and Future Directions
Harmey, D., Griffin, P. R., & Kenny, P. J. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts201 · Cited by 37
Smoking resumption after heart or lung transplantation: a systematic review and suggestions for screening and management
Hofmann, P., Benden, C., Kohler, M., & Schuurmans, M. M. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.07.16 · Cited by 37
Nicotine Replacement Therapy : An Overview
Wadgave, U., & L., N. (2016) · International Journal of Health Sciences · doi:10.12816/0048737 · Cited by 141
Exploring neurotransmitters and their receptors for breast cancer prevention and treatment
Li, R. Q., Zhao, X. H., Zhu, Q., Liu, T., Hondermarck, H., Thorne, R. F., Zhang, X. D., & Gao, J. N. (2023) · Theranostics · doi:10.7150/thno.81403 · Cited by 36
Facile fabrication of luminescent Tb@HOF-based films as a highly sensitive platform for detecting nicotine and its metabolite cotinine via fluorescence sensing and a smartphone
Hu, Z., & Yan, B. (2023) · Journal of Materials Chemistry A · doi:10.1039/d2ta09681a · Cited by 36
Whole tobacco smoke extracts to model tobacco dependence in animals
Brennan, K. A., Laugesen, M., & Truman, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.014 · Cited by 39
Targeting Nicotinic Receptors for Parkinson's Disease Therapy
Quik, M., Bordia, T., Huang, L. Z., & Perez, X. A. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711797247849 · Cited by 38
Tobacco use disorder and treatment: new challenges and opportunities
Ziedonis, D. M., Das, S., & Larkin, C. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/dziedonis · Cited by 36
Opposing effects of acute and repeated nicotine exposure on boldness in zebrafish
Dean, R., Duperreault, E., Newton, D., Krook, J., Ingraham, E., Gallup, J., Franczak, B. C., & Hamilton, T. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-65382-6 · Cited by 38
Cytochromes P450: Role in Carcinogenesis and Relevance to Cancers
Abu-Bakar, A., Tan, B. H., Halim, H., Ramli, S., Pan, Y., & Ong, C. E. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220328143828 · Cited by 36
Sulforaphane Suppresses the Nicotine-Induced Expression of the Matrix Metalloproteinase-9 via Inhibiting ROS-Mediated AP-1 and NF-κB Signaling in Human Gastric Cancer Cells
Li, S., Khoi, P. N., Yin, H. H., Sah, D. K., Kim, N., Lian, S., & Jung, Y. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095172 · Cited by 37
Neuropeptide systems and new treatments for nicotine addiction
Bruijnzeel, A. W. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4513-5 · Cited by 36
Smoke into Sound: A pilot randomised controlled trial of a music cravings management program for chronic smokers attempting to quit
Dingle, G. A., & Carter, N. A. (2017) · Musicae Scientiae · doi:10.1177/1029864916682822 · Cited by 34
Not so Cool? Menthol’s discovered actions on the nicotinic receptor and its implications for nicotine addiction
Kabbani, N. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00095 · Cited by 35
MRI Shows Lung Perfusion Changes after Vaping and Smoking
Nyilas, S., Bauman, G., Korten, I., Pusterla, O., Singer, F., Ith, M., Groen, C., Schoeni, A., Heverhagen, J. T., Christe, A., et al. (2022) · Radiology · doi:10.1148/radiol.211327 · Cited by 43
The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine
Tronci, V., Vronskaya, S., Montgomery, N., Mura, D., & Balfour, D. J. K. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1868-x · Cited by 35
Correlation between urinary nicotine, cotinine and self-reported smoking status among educated young adults
Man, C. N., Fathelrahman, A. I., Harn, G. L., Lajis, R., Samin, A. S. M., Omar, M., Awang, R., & Bayanuddin, N. A. (2009) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2009.03.003 · Cited by 34
Design, Synthesis, Structure–Activity Relationship Studies, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolase
Simone, A. D., Russo, D., Ruda, G. F., Micoli, A., Ferraro, M., Martino, R. M. C. D., Ottonello, G., Summa, M., Armirotti, A., Bandiera, T., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01578 · Cited by 35
In vivo modulation of the behavioral effects of nicotine by the coumarins xanthotoxin, bergapten, and umbelliferone
Budzyńska, B., Skalicka‐Woźniak, K., Kruk-Słomka, M., Wydrzynska-Kuźma, M., & Biała, G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4279-9 · Cited by 34
UGT2B10 Genotype Influences Nicotine Glucuronidation, Oxidation, and Consumption
Berg, J. Z., von Weymarn, L. B., Thompson, E. A., Wickham, K. M., Weisensel, N. A., Hatsukami, D. K., & Murphy, S. E. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0959 · Cited by 33
Anxiety, depression and methods of stress coping in patients with nicotine dependence syndrome
Pietras, T., Witusik, A., Panek, M., Szemraj, J., & Górski, P. (2011) · Medical Science Monitor · doi:10.12659/msm.881767 · Cited by 33
Association Between Cotinine-Verified Smoking Status and Metabolic Syndrome: Analyses of Korean National Health and Nutrition Examination Surveys 2008–2010
Kang, J., & Song, Y. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0124 · Cited by 32
Alterations in interhemispheric functional and anatomical connectivity are associated with tobacco smoking in humans
Viswanath, H., Velasquez, K. M., Thompson-Lake, D. G. Y., Savjani, R. R., Carter, A. Q., Eagleman, D. M., Baldwin, P. R., Garza, R. D. L., & Salas, R. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00116 · Cited by 32
Update on medicines for smoking cessation
McDonough, M. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.038 · Cited by 39
Gender Differences in Smoking Behaviour and Cessation
Torchalla, I., Okoli, C. T. C., Hemsing, N., & Greaves, L. (2011) · The Journal of Smoking Cessation · doi:10.1375/jsc.6.1.9 · Cited by 36
Inhibition effects of Vernonia cinerea active compounds against cytochrome P450 2A6 and human monoamine oxidases, possible targets for reduction of tobacco dependence
Prasopthum, A., Pouyfung, P., Sarapusit, S., Srisook, E., & Rongnoparut, P. (2015) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2014.12.005 · Cited by 32
Nicotine Metabolism Predicted byCYP2A6Genotypes in Relation to Smoking Cessation: A Systematic Review
Jones, S. K., Wolf, B. J., Froeliger, B., Wallace, K., Carpenter, M. J., & Alberg, A. J. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab175 · Cited by 31
Is immunotherapy an opportunity for effective treatment of drug addiction?
Zalewska-Kaszubska, J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.079 · Cited by 31
Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal
Turner, J. R., Wilkinson, D. S., Poole, R. L., Gould, T. J., Carlson, G. C., & Blendy, J. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.105 · Cited by 29
Cholinergic Receptors and Addiction
Papke, R. L., Brunzell, D. H., & Biasi, M. D. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_139 · Cited by 30
Unconventional anxiety pharmacology in zebrafish: Drugs beyond traditional anxiogenic and anxiolytic spectra
de Abreu, M. S., Giacomini, A. C. V. V., Demin, K. A., Galstyan, D. S., Zabegalov, K. N., Kolesnikova, T. O., Amstislavskaya, T. G., Strekalova, T. V., Petersen, E. V., & Kalueff, A. V. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173205 · Cited by 31
Using systems science to advance health equity in tobacco control: a causal loop diagram of smoking
Mills, S. D., Golden, S. D., O’Leary, M. C., Logan, P., & Lich, K. H. (2021) · Tobacco Control · doi:10.1136/tobaccocontrol-2021-056695 · Cited by 31
The association between changes in alternative reinforcers and short-term smoking cessation
Goelz, P. M., Audrain-McGovern, J. E., Hitsman, B. L., Leone, F. T., Veluz‐Wilkins, A. K., Jepson, C., Wileyto, E. P., D’Avanzo, P. A., Rivera, J. G., & Schnoll, R. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.02.007 · Cited by 32
Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography–tandem mass spectrometry
Vieira‐Brock, P. L., Miller, E. I., Nielsen, S. M., Fleckenstein, A. E., & Wilkins, D. G. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.09.026 · Cited by 31
Effects of Chronic Buspirone Treatment on Nicotine and Concurrent Nicotine+Cocaine Self-Administration
Mello, N. K., Fivel, P. A., & Kohut, S. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.25 · Cited by 28
Nicotine and the Neonicotinoids
Rose, P. H. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733007-00184 · Cited by 29
Heated tobacco products for smoking cessation and reducing smoking prevalence
Tattan‐Birch, H., Jackson, S. E., Shahab, L., Hartmann‐Boyce, J., Kock, L. S., Simonavičius, E., Brose, L. S., & Brown, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013790 · Cited by 29
Abuse liability assessment of the JUUL system in two nicotine concentrations compared to combustible cigarette, nicotine gum and comparator electronic nicotine delivery system
Goldenson, N. I., Buchhalter, A. R., Augustson, E. M., Rubinstein, M. L., Hoof, D. V., & Henningfield, J. E. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108441 · Cited by 30
Nicotine Does Not Enhance Tumorigenesis in Mutant K - Ras –Driven Mouse Models of Lung Cancer
Maier, C. R., Hollander, M. C., Hobbs, E. A., Doğan, İ., Linnoila, R. I., & Dennis, P. A. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0365 · Cited by 29
Optimising nicotine replacement therapy in clinical practice.
Mendelsohn, C. P. (2013) · PubMed · Cited by 29

Authors: Benowitz, N. L.
Affiliations: San Francisco General Hospital (US)
Corresponding author: Benowitz, Neal L.
ORCID: Benowitz, Neal L.
Venue: Annual Review of Pharmacology and Toxicology
Publisher: Annual Reviews
Published: 2009-02-01
Volume: 49
Issue: 1
Pages: 57-71
ISSN: 0362-1642 (ISSN-L)
1545-4304
DOI: 10.1146/annurev.pharmtox.48.113006.094742
PMC: PMC2946180
OpenAlex: W2137599927
Cited by: 979
References: 90
Citations by year: 2026: 75 · 2025: 89 · 2024: 91 · 2023: 89 · 2022: 72 · 2021: 70 · 2020: 60 · 2019: 56 · 2018: 42 · 2017: 55 · 2016: 37 · 2015: 42 · 2014: 43 · 2013: 39 · 2012: 35
FWCI: 2.95
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: The Annual Review of Pharmacology and Toxicology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Public Health Service
National Institute on Drug Abuse (DA20830, DA02277, R01DA002277, U01DA020830, R37DA002277)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords: nicotine, tobacco dependence, nicotine dependence, nicotinic acetylcholine receptors, nicotine withdrawal, dopamine release, glutamate release, GABA release, corticotropin-releasing factor, genetic susceptibility, CYP2A6, nicotine metabolism, lung cancer risk, smoking cessation, mental illness, substance abuse, nicotine replacement therapy, bupropion, varenicline, partial agonists
MeSH terms: Varenicline, Animals, Benzazepines, Nonprescription Drugs, Ganglionic Stimulants, Humans, Nicotine, Quinoxalines, Smoking, Tobacco Use Disorder, Bupropion, Behavior, Addictive, Nicotinic Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks